Taipei, Taiwan

Chu-Chun Hsueh

This inventor holds 1 USPTO granted patent. Top assignee: Industrial Technology Research Institute. Active years: 2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Chu-Chun Hsueh. Retrieved from https://idiyas.com/inventor/chu-chun-hsueh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2013

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations in Tumor Treatment by Chu-Chun Hsueh

Introduction

Chu-Chun Hsueh is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of tumors. His innovative approach involves the use of polymeric micelles to enhance drug delivery and efficacy.

Latest Patents

Chu-Chun Hsueh holds 1 patent for a drug composition aimed at treating tumors. The patent describes a pharmaceutical composition that utilizes a polymeric micelle encapsulating an anti-tumor drug. This micelle comprises block copolymers that include at least one hydrophilic block, one hydrophobic block, and one zwitterion. The invention also outlines methods to enhance the solubility of these drugs, increase their blood circulation time, and effectively deliver them to solid tumors.

Career Highlights

Hsueh is affiliated with the Industrial Technology Research Institute, where he continues to work on innovative solutions in drug development. His research focuses on improving therapeutic outcomes for patients suffering from various types of tumors.

Collaborations

He has collaborated with notable colleagues such as Yuan-Chia Chang and Yuan-Hung Hsu, contributing to advancements in their shared field of research.

Conclusion

Chu-Chun Hsueh's work exemplifies the intersection of innovation and healthcare, showcasing how targeted drug delivery systems can revolutionize tumor treatment. His contributions are paving the way for more effective therapies in oncology.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…